THC Biomed Intl Ltd. reported earnings results for the third quarter and nine months ended April 30, 2022. For the third quarter, the company reported sales was CAD 0.699004 million compared to CAD 1.11 million a year ago. Net loss was CAD 0.131108 million compared to CAD 1.32 million a year ago.
For the nine months, sales was CAD 1.78 million compared to CAD 1.93 million a year ago. Net loss was CAD 1.65 million compared to CAD 4.93 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.03 a year ago.